Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
8.21
+0.11 (1.30%)
Feb 5, 2026, 4:00 PM EST - Market closed
Bioventus Market Cap
Bioventus has a market cap or net worth of $549.88 million as of February 6, 2026. Its market cap has decreased by -16.63% in one year.
Market Cap
549.88M
Enterprise Value
848.88M
1-Year Change
-16.63%
Ranking
Category
Stock Price
$8.21
Market Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has decreased from $713.47M to $549.88M, a decrease of -22.93%. That is a compound annual growth rate of -5.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 549.88M | 10.35% |
| Dec 31, 2025 | 498.30M | -27.40% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
| Feb 11, 2021 | 713.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SI-BONE | 687.32M |
| Avanos Medical | 647.54M |
| Tactile Systems Technology | 623.16M |
| Cytek Biosciences | 615.03M |
| Beta Bionics | 615.02M |
| Perspective Therapeutics | 579.25M |
| Varex Imaging | 576.39M |
| Pacific Biosciences of California | 546.45M |